FDA CrossWalk Web1

EU Harmonized Standards May 2014

AAMI - Consensus.Standards Guidance 2001

Human Factors in Medical Devices

21 CFR Part 4

EU Regulations

FDA Guidance Standard

Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] with Different Technological Characteristics